Poster

Safety and longer-term efficacy of concizumab prophylaxis in patients with severe haemophilia A without inhibitors: Results from the extension part of the phase 2 explorer5 Trial

Author
Eichler H, Angchaisuksiri P, Astermark J, Benson G, Cepo K, Chowdary P, Hansen T, Kavakli K, Wheeler AP, Oldenburg J
Citation

Eichler H, Angchaisuksiri P, Astermark J, Benson G, Cepo K, Chowdary P, Hansen T, Kavakli K, Wheeler AP, Oldenburg J. Safety and longer-term efficacy of concizumab prophylaxis in patients with severe haemophilia A without inhibitors: Results from the extension part of the phase 2 explorer5 Trial . Haemophilia. 2021;27(S2): 95. https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14236

Date of Publication

This website is intended
for healthcare professionals (HCPs)
outside of the U.S.

Take me to www.novonordisk.com